Drug Profile
WT1 peptide-loaded dendritic cell vaccine - Medinet
Alternative Names: Peptivator-pulsed dendritic cell vaccine - MedinetLatest Information Update: 27 Dec 2019
Price :
$50
*
At a glance
- Originator Medinet
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 27 Dec 2019 No development reported - Phase-II for Solid tumours in Japan (Parenteral) (Medinet website, December 2019)
- 23 May 2016 Phase-II development is ongoing in Japan
- 01 Dec 2014 Medinet completes a phase II trial in Solid Tumours in Japan (UMIN000009447)